Medical resource use and costs among rheumatoid arthritis patients receiving disease-modifying antirheumatic drug therapy.

類似資料

• Patterns of disease-modifying antirheumatic drug use, medical resource consumption, and cost among rheumatoid arthritis patients.
  著者:: Griffiths, R, 等
  出版事項: (2001)
• Dynamics of T- and B-lymphocytes in patients with rheumatoid arthritis, receiving biological disease-modifying antirheumatic drugs
  著者:: A. V. Martynova, 等
  出版事項: (2022-02-01)
• Disease-modifying antirheumatic drugs in rheumatoid arthritis: current concepts.
  著者:: Emery, P, 等
  出版事項: (1994)
• Predictors of radiological progression of rheumatoid arthritis while receiving conventional synthetic disease-modifying antirheumatic drugs
  著者:: O. B. Iaremenko, 等
  出版事項: (2024-12-01)
• Treatment adherence to disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis
  著者:: Xia Y, 等
  出版事項: (2016-05-01)